• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Chinese guideline for percutaneous coronary intervention in patients with left main bifurcation disease].

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Apr 24;50(4):349-360. doi: 10.3760/cma.j.cn112148-20211010-00870.

DOI:10.3760/cma.j.cn112148-20211010-00870
PMID:35399031
Abstract
摘要

相似文献

1
[Chinese guideline for percutaneous coronary intervention in patients with left main bifurcation disease].[《左主干分叉病变患者经皮冠状动脉介入治疗中国专家共识》]
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Apr 24;50(4):349-360. doi: 10.3760/cma.j.cn112148-20211010-00870.
2
Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.《中国左主干分叉病变患者经皮冠状动脉介入治疗指南》
Eur Heart J. 2023 Mar 1;44(9):709-710. doi: 10.1093/eurheartj/ehac625.
3
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用：系列 PRECOMBAT（使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究）的汇总分析。
Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.
4
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响：SYNTAX 试验（紫杉醇药物洗脱支架与心脏搭桥术的联合治疗）的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
5
Clinical and Angiographic Outcomes Comparison of Patients With Left Main Vs Non-Left Main Bifurcation Lesions Treated With Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.经皮冠状动脉介入治疗联合第二代药物洗脱支架治疗左主干与非左主干分叉病变患者的临床和血管造影结果比较
J Invasive Cardiol. 2018 Dec;30(12):443-446.
6
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局：DELTA 注册研究（左主干冠状动脉疾病药物洗脱支架）：一项多中心注册研究，评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
7
Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.左主干病变与非左主干分叉病变行经皮冠状动脉介入治疗患者的治疗策略对预后的影响差异：COBIS（冠状动脉分叉病变支架置入）注册研究 II 的结果。
JACC Cardiovasc Interv. 2014 Mar;7(3):255-63. doi: 10.1016/j.jcin.2013.11.009. Epub 2014 Feb 13.
8
Outcomes of patients undergoing bifurcation vs. nonbifurcation percutaneous coronary intervention at a large tertiary center.在一家大型三级中心接受分叉病变与非分叉病变经皮冠状动脉介入治疗的患者的结局。
Hellenic J Cardiol. 2023 Mar-Apr;70:78-79. doi: 10.1016/j.hjc.2022.09.002. Epub 2022 Sep 29.
9
Coronary Bifurcation Intervention: Simpler Should Be Better?冠状动脉分叉病变介入治疗：越简单越好？
Am J Cardiol. 2023 Nov 15;207:520. doi: 10.1016/j.amjcard.2023.08.187. Epub 2023 Sep 30.
10
Tryton dedicated bifurcation stent in treatment of unprotected distal left main bifurcation disease.Tryton专用分叉支架治疗无保护左主干远端分叉病变。
Cardiovasc Revasc Med. 2018 Dec;19(8S):60-64. doi: 10.1016/j.carrev.2018.05.003. Epub 2018 May 6.

引用本文的文献

1
Review of Progress in Interventional Therapy for Coronary Bifurcation Lesions.冠状动脉分叉病变介入治疗进展综述
Rev Cardiovasc Med. 2024 Jan 4;25(1):2. doi: 10.31083/j.rcm2501002. eCollection 2024 Jan.
2
Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study.单核细胞/高密度脂蛋白胆固醇比值预测合并糖尿病的缺血性心力衰竭患者预后不良：一项回顾性研究。
Eur J Med Res. 2023 Nov 8;28(1):493. doi: 10.1186/s40001-023-01451-6.
3
A Cohort Study of the Effects of Integrated Medical and Nursing Rounds Combined with AIDET Communication Mode on Recovery and Quality of Life in Patients Undergoing Percutaneous Coronary Intervention.
一项综合医疗和护理查房联合 AIDET 沟通模式对经皮冠状动脉介入治疗患者康复和生活质量影响的队列研究。
Comput Math Methods Med. 2022 Aug 24;2022:9489203. doi: 10.1155/2022/9489203. eCollection 2022.